rs2817220
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001080.3(ALDH5A1):c.726+8G>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.252 in 1,612,044 control chromosomes in the GnomAD database, including 53,764 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_001080.3 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ALDH5A1 | NM_001080.3 | c.726+8G>A | splice_region_variant, intron_variant | ENST00000357578.8 | NP_001071.1 | |||
ALDH5A1 | NM_001368954.1 | c.726+8G>A | splice_region_variant, intron_variant | NP_001355883.1 | ||||
ALDH5A1 | NM_170740.1 | c.726+8G>A | splice_region_variant, intron_variant | NP_733936.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ALDH5A1 | ENST00000357578.8 | c.726+8G>A | splice_region_variant, intron_variant | 1 | NM_001080.3 | ENSP00000350191 | P1 |
Frequencies
GnomAD3 genomes AF: 0.244 AC: 37124AN: 152020Hom.: 4733 Cov.: 33
GnomAD3 exomes AF: 0.220 AC: 55283AN: 251196Hom.: 6673 AF XY: 0.218 AC XY: 29580AN XY: 135810
GnomAD4 exome AF: 0.253 AC: 369243AN: 1459904Hom.: 49028 Cov.: 33 AF XY: 0.249 AC XY: 180958AN XY: 726410
GnomAD4 genome AF: 0.244 AC: 37171AN: 152140Hom.: 4736 Cov.: 33 AF XY: 0.239 AC XY: 17763AN XY: 74380
ClinVar
Submissions by phenotype
Succinate-semialdehyde dehydrogenase deficiency Benign:2
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Jul 15, 2024 | This variant is classified as Benign based on local population frequency. This variant was detected in 34% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 32. Only high quality variants are reported. - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 15, 2018 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at